Immediate Impact
1 from Science/Nature 51 standout
Citing Papers
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Principles and therapeutic applications of adaptive immunity
2024 Standout
Works of Mayukh Das being referenced
First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mayukh Das | 345 | 192 | 141 | 348 | 44 | 1.0k | |
| Xiao Lin | 152 | 114 | 111 | 331 | 59 | 951 | |
| Yvonne Braun | 211 | 287 | 44 | 543 | 43 | 1.4k | |
| Tao Qu | 183 | 136 | 176 | 383 | 68 | 1.3k | |
| B. Roche | 136 | 67 | 48 | 534 | 39 | 1.3k | |
| Xiao Chu | 84 | 69 | 145 | 589 | 43 | 984 | |
| Zhiyong Xiong | 102 | 184 | 87 | 848 | 50 | 1.3k | |
| Simon Waters | 310 | 278 | 66 | 400 | 31 | 916 | |
| Francesca Andreoni | 339 | 211 | 114 | 424 | 48 | 1.3k | |
| Michel Heusterspreute | 111 | 68 | 49 | 541 | 31 | 1.0k | |
| Xueyan Duan | 156 | 168 | 87 | 781 | 41 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...